1. Home
  2. ANAB vs SCVL Comparison

ANAB vs SCVL Comparison

Compare ANAB & SCVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANAB
  • SCVL
  • Stock Information
  • Founded
  • ANAB 2005
  • SCVL 1978
  • Country
  • ANAB United States
  • SCVL United States
  • Employees
  • ANAB N/A
  • SCVL N/A
  • Industry
  • ANAB Biotechnology: Pharmaceutical Preparations
  • SCVL Clothing/Shoe/Accessory Stores
  • Sector
  • ANAB Health Care
  • SCVL Consumer Discretionary
  • Exchange
  • ANAB Nasdaq
  • SCVL Nasdaq
  • Market Cap
  • ANAB 759.5M
  • SCVL 609.8M
  • IPO Year
  • ANAB 2017
  • SCVL 1993
  • Fundamental
  • Price
  • ANAB $20.55
  • SCVL $17.26
  • Analyst Decision
  • ANAB Buy
  • SCVL Strong Buy
  • Analyst Count
  • ANAB 10
  • SCVL 1
  • Target Price
  • ANAB $36.38
  • SCVL $51.00
  • AVG Volume (30 Days)
  • ANAB 1.0M
  • SCVL 669.9K
  • Earning Date
  • ANAB 05-08-2025
  • SCVL 05-22-2025
  • Dividend Yield
  • ANAB N/A
  • SCVL 3.48%
  • EPS Growth
  • ANAB N/A
  • SCVL N/A
  • EPS
  • ANAB N/A
  • SCVL 2.68
  • Revenue
  • ANAB $91,280,000.00
  • SCVL $1,202,885,000.00
  • Revenue This Year
  • ANAB N/A
  • SCVL $1.17
  • Revenue Next Year
  • ANAB $37.76
  • SCVL $4.11
  • P/E Ratio
  • ANAB N/A
  • SCVL $6.44
  • Revenue Growth
  • ANAB 432.03
  • SCVL 2.30
  • 52 Week Low
  • ANAB $12.21
  • SCVL $16.53
  • 52 Week High
  • ANAB $41.31
  • SCVL $46.92
  • Technical
  • Relative Strength Index (RSI)
  • ANAB 65.12
  • SCVL 34.03
  • Support Level
  • ANAB $15.40
  • SCVL $16.53
  • Resistance Level
  • ANAB $19.82
  • SCVL $19.48
  • Average True Range (ATR)
  • ANAB 1.49
  • SCVL 1.56
  • MACD
  • ANAB 0.16
  • SCVL -0.30
  • Stochastic Oscillator
  • ANAB 96.26
  • SCVL 11.25

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, our PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, our BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

About SCVL Shoe Carnival Inc.

Shoe Carnival Inc is a family footwear retailer that offers a broad assortment of dress, casual and athletic footwear for men, women, and children with an emphasis on national name brands such as Nike, Skechers, Adidas, Puma, HEYDUDE, Converse, Vans, and Crocs. They operate their business as one reportable segment based on the similar nature of products sold; merchandising, distribution, and marketing processes involved; target customers; and economic characteristics of our stores and e-commerce platforms. Its bricks-first, omnichannel approach provides customers easy access to a wide assortment of branded footwear for work, athletics, daily activities, and special events via a choice of delivery channel.

Share on Social Networks: